Hotovely-Salomon
Anna Hotovely-Salomon, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20090263482 | Treatment of inflammatory bowel disease with 6-mercaptopurine - Methods of administering a delayed release 6-mercaptopurine pharmaceutical composition to patients suffering from inflammatory bowel disease which provide for release of the 6-mercaptopurine after passage of the pharmaceutical composition through the stomach are disclosed. The methods result in significant clinical improvement despite leading to very little systemic absorption of 6-mercaptopurine and also result in very few undesirable side effects. | 10-22-2009 |
20140370105 | TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH 6-MERCAPTOPURINE - Methods of administering a delayed release 6-mercaptopurine pharmaceutical composition to patients suffering from inflammatory bowel disease which provide for release of the 6-mercaptopurine after passage of the pharmaceutical composition through the stomach are disclosed. The methods result in significant clinical improvement despite leading to very little systemic absorption of 6-mercaptopurine and also result in very few undesirable side effects. | 12-18-2014 |
Anna Hotovely-Salomon, Jerusalem, IL US
Patent application number | Description | Published |
---|---|---|
20130280328 | TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH 6-MERCAPTOPURINE - Methods of administering a delayed release 6-mercaptopurine pharmaceutical composition to patients suffering from inflammatory bowel disease which provide for release of the 6-mercaptopurine after passage of the pharmaceutical composition through the stomach are disclosed. The methods result in significant clinical improvement despite leading to very little systemic absorption of 6-mercaptopurine and also result in very few undesirable side effects. | 10-24-2013 |
Anna Hotovely-Salomon, Modi'In Maccabim Re'Ut IL
Patent application number | Description | Published |
---|---|---|
20150313904 | TREATMENT OF CROHN'S DISEASE WITH DELAYED-RELEASE 6-MERCAPTOPURINE - Methods of treating patients suffering from Crohn's disease or ulcerative colitis who did not experience a clinical response to previous thiopurine administration, or suffered side effects from previous thiopurine administration, by administering a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed. Methods of treating patients suffering from Crohn's disease or ulcerative colitis who are also being administered a steroid, 5-aminosalicylic acid, or an antibiotic by adjunctively administering a delayed release pharmaceutical composition comprising 6-mercaptopurine are also disclosed. | 11-05-2015 |